US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 22, 2015 (11 years ago)

Captopril Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Firm did not adequately investigate customer complaints.

What was recalled

Captopril Tablets, USP, 100 mg Tablets, Packaged in 100 Count Bottles, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0905-01.

Recalling firm
Wockhardt Usa Inc.
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1277-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Captopril recalls

See all
Class II · Moderate risk Terminated

Captopril Tablets

Reason cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure

Blenheim Pharmacal, Inc. NDC 10544-175-30 D-1109-2015
Class II · Moderate risk Terminated

Captopril Tablets

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1276-2015
Class II · Moderate risk Terminated

Captopril Tablets

Reason CGMP Deviations: Firm did not adequately investigate customer complaints.

Wockhardt Usa Inc. D-1275-2015
Class II · Moderate risk Terminated

Captopril Tablets

Reason Failed Tablet/Capsule Specifications: out of specification for thickness.

Wockhardt Usa Inc. NDC 64679-902-01 D-0975-2015